MENU
INTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Intensity Therapeutics (INTS) Ownership - Who owns Intensity Therapeutics?
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more
Profile
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.42M
P/E Ratio
N/A
Total Cash
929K
Projected Growth
N/A
Total Debt
131K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INTS
Capitalization
12.4M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
929K
Total Cash/Share
0.02
Total Debt
131K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
334K
P/B Ratio
5.69
Cash Flow
N/A
Earnings
-1.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
0.63
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-14.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-194.04
Shares Held By Institutions
3.77M
Shares Outstanding - Current
46M
Total Liabilities
2.73M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-84.665
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INTS showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com